Aprea Therapeutics (APRE) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Outperform | $3.00 from $6.00 | Aug 13, 2026 |
| Wedbush | Maintained | Outperform | $6.00 from $7.00 | May 14, 2026 |
| Oppenheimer | Initiated Coverage | Outperform | $5.00 | May 7, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $1.20 from $4.00 | Mar 31, 2026 |
| Wedbush | Maintained | Outperform | $7.00 | Mar 31, 2026 |
| Wedbush | Maintained | Outperform | $7.00 from $11.00 | Feb 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 from $5.00 | Jan 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $20.00 | Dec 18, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jan 15, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Dec 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Nov 18, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Oct 24, 2024 |
| Wedbush | Maintained | Outperform | $11.00 | Aug 13, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Aug 12, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jun 24, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jun 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | May 14, 2024 |
| Wedbush | Maintained | Outperform | $11.00 from $9.00 | Mar 27, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Mar 26, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Nov 1, 2023 |
Frequently asked questions
Is APRE a buy, sell, or hold?
Analysts covering Aprea Therapeutics currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on APRE?
On Aug 13, 2026, Wedbush maintained Aprea Therapeutics at Outperform with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.